VANILLIN

Molecular Excipient

Mwt. LogP HBD HBA PSA RB CSP3
152.0 1.2 1 3 47.0 2 0.13
UNII
CHI530446X
CAS
121-33-5
SYNONYMS
  • Vanillin
  • Methylprotocatechuic Aldehyde
  • Nsc-15351
  • Vanillaldehyde
  • Vanillic Aldehyde
  • Fema No. 3107
  • Vanillin [ep]
  • Vanillin [mart.]
  • Vanillin [mi]
  • Vanillin [inci]
  • Vanillin [fcc]
  • Vanillin [fhfi]
  • Vanillin [ii]
  • Vanillin [hsdb]
  • Vanillin [vandf]
  • Nplc-0145
  • H-0264
  • 3-Methoxy-4-Hydroxybenzaldehyde
  • 4-Hydroxy-3-Methoxy-Benzyldehyde
  • P-Hydroxy-M-Methoxybenzaldehyde
  • 4-Hydroxy-M-Anisaldehyde
  • Nsc-403658
  • Nsc-48383
  • Rhovanil
  • Lioxin
  • Vanillin Melting Point Standard [usp-Rs]
  • 4-Hydroxy-3-Methoxybenzaldehyde
  • Vanillin Melting Point Standard
ZINC ID(s)
Availability
Present in 87 ZINC catalogs

Known Active Genes

There has not been any activity reported at 10μM or less for this excipient (per ChEBML)

Clinical Trials

This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).

(Browse) Purchasable Analogs in ZINC

Regulatory Status of Vanillin

Gras - Generally recognized as safe.

Dosages

Route Formulation Per Unit Dose
Oral Capsule 0.94MG
Oral Capsule, Sustained Action 0.94MG
Oral Emulsion
Oral Powder
Oral Powder, For Suspension 0.16%
Oral Solution 0.05%
Oral Solution, Elixir 0.0003%
Oral Suspension 0.1%
Oral Syrup
Oral Tablet 1.5MG
Oral Tablet (immed./comp. Release), Uncoated, Chewable 2.5MG
Oral Tablet, Coated 65.5MG
Oral Tablet, Delayed Action 0.8MG
Oral Tablet, Delayed Action, Enteric Coated 1.16MG
Oral Tablet, Enteric Coated Particles 0.7MG
Oral Tablet, Film Coated 0.78MG
Oral Tablet, Sustained Action 3.4MG
Oral Tablet, Sustained Action, Film Coated 0.8MG

More Information

Usage Over Time

Comments